AKTS Aktis Oncology, Inc.

Fundamentals / CIK 0002035832 / USD

Aktis Oncology, Inc. reported $532.5M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AKTS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for AKTS.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Revenue $3.90M $3.38M $3.23M $1.58M $1.60M $1.45M
Research & Development $32.12M $25.28M $20.04M $16.47M $18.63M $15.86M
Total Operating Expenses $38.65M $32.28M $25.93M $19.78M $22.56M $19.59M
Operating Income -$34.75M -$28.90M -$22.71M -$18.20M -$20.96M -$18.14M
EBITDA -$33.80M -$28.02M -$22.05M -$17.61M -$20.41M -$17.66M
Interest Income $4.82M $4.76M $4.38M $2.68M $2.91M $3.17M
Net Income -$29.94M -$24.14M -$18.32M -$15.53M -$18.07M -$14.98M
Basic EPS -$0.54 -$0.44 -$0.38 -$19.18 -$22.39 -$18.60
Diluted EPS -$0.54 -$0.44 -$0.38 -$19.18 -$22.39 -$18.60
Basic Shares Outstanding 55.6M 55.3M 48.6M 809.8K 807.3K 805.8K
Diluted Shares Outstanding 55.6M 55.3M 48.6M 809.8K 807.3K 805.8K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for AKTS.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $68.32M $82.49M $371.6M $37.78M
Cash & Short-Term Investments $492.9M $517.3M $538.5M $37.78M
Total Current Assets $499.9M $524.5M $543.9M $230.3M
Property, Plant & Equipment, Net $15.37M $15.97M $15.29M $14.60M
Total Non-Current Assets $32.60M $33.06M $32.86M $34.58M
Total Assets $532.5M $557.6M $576.8M $264.9M
Accounts Payable $1.44M $2.53M $1.23M $1.74M
Deferred Revenue (Current) $15.23M $17.34M $18.96M $18.66M
Total Current Liabilities $35.16M $32.13M $27.91M $31.24M
Deferred Revenue (Non-Current) $29.07M $30.87M $32.63M $36.16M
Total Non-Current Liabilities $38.45M $40.63M $42.78M $46.39M
Total Liabilities $73.61M $72.76M $70.69M $77.62M
Total Debt (incl. Leases) $10.84M $11.24M $11.58M $11.55M
Retained Earnings -$229.0M -$199.0M -$174.9M -$156.6M
Accumulated Other Comp. Income -$1.93M -$745K -$241K $42K
Total Stockholders' Equity $458.9M $484.8M $506.1M -$146.1M
Total Equity $458.9M $484.8M $506.1M -$146.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for AKTS.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$29.94M -$24.14M -$18.32M -$15.53M -$18.07M -$14.98M
Depreciation & Amortization $942K $879K $652K $598K $552K $484K
Stock-Based Compensation $3.45M $3.22M $3.02M $1.28M $1.52M $1.24M
Change in Payables -$667K $866K -$65K $392K -$115K $90K
Operating Cash Flow -$26.05M -$20.59M -$24.24M -$15.22M -$16.18M -$17.48M
Capital Expenditure -$772K -$1.26M -$1.85M -$2.00M -$1.53M -$1.89M
Free Cash Flow -$26.82M -$21.85M -$26.10M -$17.23M -$17.71M -$19.38M
Purchases of Investments -$56.24M -$300.4M $0 $0 $0 -$10.82M
Investing Cash Flow $10.17M -$268.7M $20.54M $85.23M $68.14M $39.04M
Common Stock Issued -- -- $5.38M -- -- --
Financing Cash Flow $1.71M $156K $337.5M $28K $0 -$468K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for AKTS.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 14.22x 16.33x 19.49x -- -- --
Quick Ratio 14.02x 16.10x 19.29x -- -- --
Debt to Equity 0.02x 0.02x 0.02x -- -- --
Revenue Growth (YoY) +147.3% +111.4% +123.0% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002035832) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:31 UTC · Open in terminal